Why Doctors Do Not Recommend White Blood Cell Boosting Injections
Generally speaking, the white blood cell boosting injection refers to recombinant human granulocyte colony-stimulating factor injection. Reasons why doctors may not recommend administering recombinant human granulocyte colony-stimulating factor injection may include cost factors, drug indications, allergic reactions, gastrointestinal discomfort, decreased immunity, and other factors. A detailed analysis is as follows:
1. Cost Factors
Recombinant human granulocyte colony-stimulating factor injection is relatively expensive, typically priced between 100 to 400 yuan per dose. Repeated use may increase the economic burden on patients. Therefore, when considering the use of this drug, doctors will also take into account the patient's financial situation. For patients without clear clinical indications, frequent use of this injection not only increases personal or family financial burdens but may also consume limited medical resources.
2. Drug Indications
This injection is mainly used to treat granulocytopenia, including neutropenia caused by cancer chemotherapy and neutropenia associated with myelodysplastic syndromes. If the patient's condition does not meet these indications, inappropriate use may pose a threat to the patient's health.
3. Allergic Reactions
For patients with hypersensitive constitutions, administration of recombinant human granulocyte colony-stimulating factor injection may trigger severe allergic reactions such as rash, difficulty breathing, and in extreme cases, it may even be life-threatening.
4. Gastrointestinal Discomfort
Some patients may experience gastrointestinal symptoms such as nausea, vomiting, or diarrhea after injection. These symptoms can affect the patient's quality of life and may also interfere with drug absorption and effectiveness.
5. Decreased Immunity
Long-term use of recombinant human granulocyte colony-stimulating factor injection may cause immune dysfunction, leading to reduced immunity. This could make patients more susceptible to illness.
If a patient's condition requires the use of recombinant human granulocyte colony-stimulating factor injection, doctors will provide professional recommendations and guidance on proper medication use. Meanwhile, patients should closely monitor their physical reactions during treatment and seek medical attention promptly if any adverse symptoms occur.